news banner 2107 2



Developing the next generation of malaria researchers

on .


The MLW Malaria Theme has equipped its team with leadership skills with the aim of empowering them to interact with partners in the fight against the epidemic.

The 5-day training attracted participants from MLW and other collaborating institutions including the College of Medicine, Malaria Alert Centre and the Polytechnic.

In her opening remarks, the Malaria Theme Lead, Dr Anja Terlouw, said she saw the need for the ‘Practice of Leadership in Health’ training after seeing a gap in leadership training at colleges. “There is a strong need for leadership skills, peer based learning and collaboration in order for the malaria group members to benefit from the diversity within the group” she said.

The course equipped participants with a number of skills, including vision and decision making, communication, people management, technical capacity, and emotional intelligence.


“More networking and collaborations needed in the fight against Tuberculosis” researchers have said.

on .

tamiwetomokasDr Tamiwe Tomoka, Director of The Helse Nord TB Initiative (HTNI) at the College of Medicine making her presentation

For the global TB targets to be achieved there is need for countries to come up with specific TB research network agenda, be able to fund their own research and work towards addressing gaps in detection, treatment, funding and develop new tools in the fight against the disease.

These remarks were made by Dr Tamiwe Tomoka, Director of The Helse Nord TB Initiative (HTNI) at the College of Medicine, during a Research Disseminating meeting organized by the Malawi Liverpool Wellcome Trust’s (MLW) TB & HIV Research group in collaboration with various stakeholders from the health sector.

The HTNI is a Joint College of Medicine (CoM) and MLW initiative which among other things is aimed at building the capacity of researchers through training and the formation of a research and training group for networking, collaboration and meetings.


Malaria Researchers at MLW Receive EDCTP Grant to Review Evidence on Safety of Antimalarial Drug

on .


The European and Developing Countries Clinical Trials Partnership (EDCTP), have awarded the Malaria Epidemiology Group at the Malawi-Liverpool-Wellcome Trust (MLW) a “Coordination & Support Actions” grant to support the translation of findings from the previously EDCTP-funded ADAPT 1 & 2 and ADJusT trials towards treatment policy and health impact.


The project called IMPACT aims at reviewing and raising awareness of dose optimisation research priorities for key risk groups among researchers, funders and control programmes. The work will focus on the antimalarial dihydroartemisinin-piperaquine (DHA-PPQ), one of the World Health Organization (WHO) recommended drugs to treat uncomplicated malaria.